All sites now recruiting

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

All sites now recruiting

posted on Jul 28, 2016 03:03PM

A Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer

Updated yesterday. All sites now recruiting. Also, name of sponsor changed from "Zenith Epigenetics Corp." to "Zenith Epigenetics".

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply